Article
Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Oct 2012
Moschidou Dafni, Mukherjee Sayandip, Blundell Michael P, Drews Katharina, Jones Gemma N, Abdulrazzak Hassan, Nowakowska Beata, Phoolchund Anju, Lay Kenneth, Ramasamy T Selvee, Cananzi Mara, Nettersheim Daniel, Sullivan Mark, Frost Jennifer, Moore Gudrun, Vermeesch Joris R, Fisk Nicholas M, Thrasher Adrian J, Atala Anthony, Adjaye James, Schorle Hubert, De Coppi Paolo, Guillot Pascale V
Abstract excerpt
Induced pluripotent stem cells (iPSCs) with potential for therapeutic applications can be derived from somatic cells via ectopic expression of a set of limited and defined transcription factors. However, due to risks of random integration of the reprogramming transgenes into the host genome, the low efficiency of the process, and the potential risk of virally induced tumorigenicity, alternative methods have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
